Immunization against Salmonella typhi

Infectious Diseases in Clinical Practice

Volumn 4, Issue 2, 1995, Pages 114-122

  Bennish, Michael L ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; INACTIVATED VACCINE; LIVE VACCINE; TYPHOID VACCINE;

ACTIVE IMMUNIZATION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; ENTERIC COATED TABLET; FEVER; HUMAN; INDUSTRIALIZATION; INFECTION RISK; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PAIN; PHARMACEUTICS; REVIEW; SALMONELLA TYPHI; SUBCUTANEOUS DRUG ADMINISTRATION; THERMAL EXPOSURE; TYPHOID FEVER;

EID: 0028903748     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/00019048-199503000-00011     Document Type: Article

References (51)

1. Butler T, Knight J, Nath SK, Speelman P, Roy SK, Azad МAK. Typhoid fever complicated by, intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis. 1985;7:244-56.
2. Hoffman SL, Punjabi NH, Kumala S, et al. Reduction in mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med. 1984;310: 82-8.
3. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ. Typhoid fever: pathogenesis and immunologic control. N Engl J Med. 1970;283(2 Pt 1):686-91.
4. Islam A, Butler T, Ward LR. Reinfection with a different Vi-phage type of Salmonella typhi in an endemic area [letter]. J Infect Dis. 1987; 155:155-6.
5. Woodward TE, Smadel JE, Parker RT, Wisse-man CL. Treatment of typhoid fever with antibiotics. Ann Ν Y Acad Sci. 1952;55:1043-55.
6. Threlfall EJ, Ward LR, Rowe B, et al. Widespread occurrence of multiple drug-resistant Salmonella typhi in India. Eur J Clin Microbiol Infect Dis. 1992;11:990-3.
7. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1992. MMWR Morb Mortal Wkly Rep. 1992; 41(55):67-73.
8. Ryan CA, Hargrett-Bean NT, Blake PA. Salmonella typhi infection in the United States, 1975-1984: increasing role of foreign travel. Rev Infect Dis. 1989;11:1-8.
9. Steffen R. Epidemiologic studies of travelers', diarrhea, severe gastrointestinal infections, and cholera. Rev Infect Dis. 1986;6(2 Suppl): 122S-130S.
10. Blaser MJ, Hickman FW, Farmer JL III, Brenner DJ, Balows A, Feldman RA. Salmonella typhi: the laboratory as a reservoir of infection. J Infect Dis. 1980;142:934-8.
11. Committee on Issues and Priorities for New Vaccine Development. The prospects of immunizing against Salmonella typhi. In: Katz SL, editor. New vaccine development: establishing priorities. Vol 2. Diseases of importance in developing countries. Washington (DC): National Academy Press, 1986:322.
12. Mahle WT, Levine MM. Salmonella typhi infection in children younger than five years of age. Pediatr Infect Dis J. 1993;12:627-31.
13. Groschel DHM, Hornick RB. Who introduced typhoid vaccination: Almoth Wright or Richard Pfeiffer? Rev Infect Dis. 1981;3:1251-4.
14. Levine MM, Ferreccio C, Black RB, Tacket CO, Germanier R, Chilean Typhoid Committee. Progress in vaccines against typhoid fever. Rev Infect Dis. 1989;11(3 Suppl):552S-567S.
15. Yugoslav Typhoid Commission. Field and laboratory studies with typhoid vaccines. Bull World Health Organ. 1957;16:897-910.
16. Yugoslav Typhoid Commission. A controlled field trial of the effectiveness of phenol and alcohol typhoid vaccines. Bull World Health Organ. 1962;26:357-69.
17. Cvjetanovic B, Uemura K. The present status of field and laboratory studies of typhoid and paratyphoid vaccines with special reference to studies sponsored by the World Health Organization. Bull World Health Organ. 1965;32:29-36.
18. Polish Typhoid Committee. Controlled field trials and laboratory studies on the effectiveness of typhoid vaccines in Poland 1961-64. Bull World Health Organ. 1966;34:211-22.
19. Ashcroft MT, Singh B, Nicholson CC, Ritchie JM, Sobryan E, William F. A seven-year field trial of two typhoid vaccines in Guiana. Lancet. 1967;2:1056-60.
20. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ. Typhoid fever: pathogenesis and immunologic control. N Engl J Med. 1970;283(2 Pt 2):739-46.
21. Centers for Disease Control and Prevention. Typhoid immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1994;43(RR-14):1-7.
22. Tacket CO, Losonsky G, Taylor DN, et al. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21 a in human studies. J Infect Dis. 1991;163:901-4.
23. Forrest BD, LaBrooy JT, Beyer L, Dearlove CE, Shearman DJC. The human humoral immune response to Salmonella fypn/Ty21a. J Infect Dis. 1991;163:336-45.
24. Levine MM, Ferreccio C, Cryz S, Ortiz E. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet. 1990;336:891-4.
25. Ferreccio C, Levine MM, Rodriguez H, Contreras R, Chilean Typhoid Committee. Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area. J Infect Dis. 1989;159:766-9.
26. Levine MM, Ferreccio C, Black RE, Germanier R, Chilean Typhoid Committee. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet. 1987;1:1049-52.
27. Simanjuntak CH, Paleólogo FP, Punjabi NH, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet. 1991;338:1055-9.
28. Wahden MH, Serie С, Cerisier Y, Sallam S, Germanier R. A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: three-year results. J Infect Dis. 1982;145:292-5.
29. Gilman RH, Hornick RB, Woodward WE, et al. Evaluation of a UDP-glucose-4-epimerase-less mutant of Salmonella typhi as a live oral vaccine. J Infect Dis. 1977;136:717-23.
30. Levine MM, Taylor DN, Ferreccio C. Typhoid vaccines come of age. Pediatr Infect Dis J. 1989;8:374-81.
31. Cryz SJ Jr., Vanprapar N, Thisyakorn U, et al. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. Infect Immun. 1993;61:1149-51.
32. Rahman S, Barr W, Hilton E. Use of oral typhoid vaccine strain Ty21a in a New York State travel immunization facility. Am J Trop Med Hyg. 1993;48:823-6.
33. Murphy Jr, Grez L, Schlesinger L, et al. Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect Immun. 1991;59: 4291-3.
34. Brachman PS, Metchock B, Kozarsky PE. Effects of antimalarial chemoprophylactic agents on the viability of the Ty21a typhoid vaccine strain [letter]. Clin Infect Dis. 1992; 15:1057-8.
35. Horowitz H, Carbonaro CA. Inhibition of the Salmonella typhi oral vaccine strain, Ty21a, by mefloquine and chloroquine [letter]. J Infect Dis. 1992;166:1462-4.
36. Kaplan DT, Hill DR. Compliance with live, oral Ty21a typhoid vaccine [letter]. JAMA. 1992;267:1074.
37. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR Morb Mortal Wkly Rep. 1993;42(RR-4):1-18.
38. Wilson ME, von Reyn CF, Fineberg HV. Infections in HIV-infected travelers: risks and prevention. Ann Intern Med. 1991;114:58292.
39. Acharya IL, Lowe CU, Thapa R, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N Engl J Med. 1987;317:1101-4.
40. Klugman KP, Gilbertson IT, Koornhof HJ, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet. 1987;2:1165-9.
41. Cumberland NS, Roberts JSC, Arnold WSG, Patel RK, Bowker CH. Typhoid Vi: a less re-actogenic vaccine. J Int Med Res. 1992;20: 247-53.
42. Steffen R, Schär G, Mosimann J. Salmonella and shigella infections in Switzerland, with special reference to typhoid vaccinations for travelers. Scand J Infect Dis. 1981;13:121-7.
43. [Anonymous]. Typhoid vaccination: weighing the options. Lancet. 1992;340:341-2.
44. Schwartz E, Shlim DR, Eaton M, Jenks N, Houston R. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch Intern Med. 1990;150:349-51.
45. Schwartz E, Shlim DR. Enteric fever among Israeli travelers in Nepal: the need for typhoid vaccination. Isr J Med Sci. 1990;26:325-7.
46. Yugoslav Typhoid Commission. A controlled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol inactivated typhoid vaccines in Yugoslavia. Bull World Health Organ. 1964;30:623-30.
47. Hejfec LB. Results of the study of typhoid vaccines in four controlled field trials in the USSR. Bull World Health Organ. 1965;32:1-14.
48. Bodhidatta L, Taylor DN, Thisyakorn U, Echeverría P. Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine. Rev Infect Dis. 1987;9:841-5.
49. Kim-Farley RJ. EPI for the 1990s. The Expanded Program on Immunization team. Vaccine. 1992;10:940-8.
50. Woodruf BA, Pavia AT, Blake PA. A new look at typhoid vaccination. Information for the practicing physician. JAMA. 1991;265: 756-9.
51. Kozicki M, Steffen R, Schar M. Boil it, cook it, peel it, or forget it. Int J Epidemiol. 1985;14: 169-72.